Skip to main content
BMC Research Notes logoLink to BMC Research Notes
. 2013 Aug 20;6:332. doi: 10.1186/1756-0500-6-332

Retraction: Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report

Jan Øystein Berle 1,, Else-Marie Løberg, Ole Bernt Fasmer
PMCID: PMC3844366  PMID: 23962164

Retraction

The authors have retracted this article [1] as the fMRI data presented in the case report are incorrect. The activation data reported for session 1 are the activation data for session 2 and vice versa. As a result the discussion and conclusions of the case report are based on the wrong set of data and are no longer valid. The authors apologise for the error.

Contributor Information

Jan Øystein Berle, Email: jaob@helse-bergen.no.

Else-Marie Løberg, Email: else.marie.loeberg@psych.uib.no.

Ole Bernt Fasmer, Email: ole.fasmer@kliniskmedisin.uib.no.

References

  1. Berle JØ, Else-Marie L, Ole Bernt F. Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report. BMC Research Notes. 2013;6:182. doi: 10.1186/1756-0500-6-182. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from BMC Research Notes are provided here courtesy of BMC

RESOURCES